NESTABS DHA PRENATAL MULTI-VITAMIN/MINERAL SUPPLEMENT WITH DHA/EPA- sodium ascorbate, cholecalciferol, di-alpha-tocopheryl acetate, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hcl, folic acid, cyanocobalamin, calcium formate, calcium carbonate, ferrous (ii) bis-glycinate chelate, potassium iodide, zinc oxide, choline bitartrate, with doconexent and icosapent
WOMENS CHOICE PHARMACEUTICALS LLC
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
D
escripton: Nestabs DHA combination
tablet-capsule for oral administration is a light pink capsule-shaped film
coated tablet with a pleasant sweet flavor with WCOO1 imprinted on one side of
the tablet and a enteric coated light amber soft gel capsule omega-3 fatty acid
containing both DHA and EPA.
I
ndications and Usage: Nestabs DHA is indicated
to provide vitamin/mineral and omega-3 fatty acid supplementation to women
throughout pregnancy, during the postnatal for both lactating and nonlactating
mothers. Nestabs DHA is also beneficial in improving the nutritional status of
women prior to conception.
C
ontraindications:
This product is contraindicated in patients with a known
hypersensitivity to any of the ingredients
.
W arnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
WARNING:
Accidental
overdose of iron-containing products is a leading cause of fatal poisoning in
children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of
accidental overdose, call a doctor or poison control center immediately.
P
recautions: Folic acid in doses above 0.1mg daily
may obscure pernicious anemia in that hematologic remission can occur while
neurological manifestations remain progressive. This product contains formate,
which if consumed above the recommended level, could cause visual impairment
and other health effects. Do not take more than the recommended amount. If you
are pregnant, nursing, or taking any medications consult your doctor before
use. Discontinue use and consult your doctor if any adverse reactions occur.
Not intended for use by persons under the age of 18.
A
dverse Reactions: Allergic sensitization has
been reported following both oral and parenteral administration of folic acid.
D
osage and Administration: Nestabs DHA - One
tablet and one soft gel capsule daily or as directed by a physician.
H
ow Supplied: Nestabs DHA tablets for oral
administration are supplied as six child-resistant blister cards containing 5
tablets and 5 softgel capsules each (NDC# 50967-317-30).